Advances in mRNA Vaccines
An mRNA vaccine is a type of vaccine that uses a copy of a molecule called messenger RNA (mRNA) to produce an immune response. The vaccine delivers molecules of antigen-encoding mRNA into cells, which use the designed mRNA as a blueprint to build foreign protein that would normally be produced by a pathogen (such as a virus) or by a cancer cell. These protein molecules stimulate an adaptive immune response that teaches the body to identify and destroy the corresponding pathogen or cancer cells. The mRNA is delivered by a co-formulation of the RNA encapsulated in lipid nanoparticles that protect the RNA strands and help their absorption into the cells.
In the present book, eleven typical literatures about mRNA vaccines published on international authoritative journals were selected to introduce the worldwide newest progress, which contains reviews or original researches on mRNA vaccines. We hope this book can demonstrate advances in mRNA vaccines as well as give references to the researchers, students and other related people.
Sample Chapter(s)
Preface (174 KB)
Components of the Book:
  • Chapter 1
    A Comprehensive Review of mRNA Vaccines
  • Chapter 2
    mRNA cancer vaccines from bench to bedside: a new era in cancer immunotherapy
  • Chapter 3
    Self-Amplifying RNA Vaccine Candidates: Alternative Platforms for mRNA Vaccine Development
  • Chapter 4
    RETRACTED ARTICLE: An overview on mRNA-based vaccines to prevent monkeypox infection
  • Chapter 5
    Updated Considerations for the Immunopharmacological Aspects of the “Talented mRNA Vaccines”
  • Chapter 6
    Key considerations for a prostate cancer mRNA vaccine
  • Chapter 7
    DDO-adjuvanted influenza A virus nucleoprotein mRNA vaccine induces robust humoral and cellular type 1 immune responses and protects mice from challenge
  • Chapter 8
    Prospects and Challenges in Developing mRNA Vaccines for Infectious Diseases and Oncogenic Viruses
  • Chapter 9
    The potential use of therapeutics and prophylactic mRNA vaccines in human papillomavirus (HPV)
  • Chapter 10
    Innate and Adaptive Immune Parameters following mRNA Vaccination in Mice
  • Chapter 11
    Advancing personalized medicine in brain cancer: exploring the role of mRNA vaccines
Readership: Students, academics, teachers and other people attending or interested in mRNA vaccines.
Sushesh Srivatsa Palakurthi
Department of Pharmaceutical Sciences, Irma Lerma Rangel School of Pharmacy, Texas A&M University, Kingsville, TX 78363, USA

Cristiana Perrotta
Department of Biomedical and Clinical Sciences (DIBIC), Università degli Studi di Milano, 20157 Milano, Italy

Ahmed Elkashif
School of Pharmacy, Queen's University Belfast, 97 Lisburn Road, Belfast BT9 7BL, UK

and more...
Copyright © 2006-2025 Scientific Research Publishing Inc. All Rights Reserved.
Top